Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share
Tweet Send to a FriendGet Alerts CBLI Hot Sheet
Price: $1.66 +1.22%
EPS Growth %: -46.7%
Financial Fact:
Research and development: 5.33M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: -46.7%
Financial Fact:
Research and development: 5.33M
Today's EPS Names:
ANF, DXLG, FL, More
Trade CBLI Now!
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $931 thousand versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Perry Ellis Int'l (PERY) Misses Q1 EPS by 1c; Reaffirms Outlook
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
